Delivery Order SPE2DR25D2104-SPE2DR26F3NVR
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,859.04 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder used to treat chronic obstructive pulmonary disease. This competitively awarded, firm fixed-price delivery order was issued on September 11, 2025, with an ultimate completion date of September 12, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $44,129.70 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation powder medication used in respiratory disease treatment. The contract was awarded on November 6, 2025, with an ultimate completion date of November 7, 2025, and is structured as a firm fixed price delivery order with no set-aside designation. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $2,826.71 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used in respiratory disease treatment. This firm fixed-price delivery order, issued on July 18, 2025, represents a competitive award with no set-aside designation and is scheduled for completion by July 21, 2025. The product will be delivered to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $3,618.42 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 (60-count supply), a combination inhalation powder medication used in respiratory disease treatment. This firm fixed price, competitively awarded delivery order was issued on September 5, 2025, with an ultimate completion date of September 8, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,076.77 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 inhalers (60-count supply). This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of July 22, 2025. The award was made to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, the company's headquarters location, which also serves as the place of performance for...
- The Defense Logistics Agency awarded a delivery order valued at $4,001.90 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used in respiratory disease management. This firm fixed-price delivery order, issued on July 14, 2025, with an ultimate completion date of July 15, 2025, represents a non-competitive, non-set-aside award. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,143.65 for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used in respiratory disease management. This competitively awarded, firm fixed-price delivery order was issued on September 11, 2025, with an ultimate completion date of September 12, 2025, and represents a direct purchase under an existing contract vehicle. The award carries no set-aside designation, reflecting...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,604.40 for TRELEGY ELLIPTA 100-62.5-25 (60 count), a combination inhalation powder used in respiratory disease treatment. Issued on September 2, 2025, with an ultimate completion date of September 3, 2025, this firm fixed-price delivery order represents a routine pharmaceutical supply transaction under a non-competitive, non-set-aside procurement. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $20,089.16 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination pulmonary medication supplied in a 60-dose inhaler. The contract was awarded on April 24, 2025, with an ultimate completion date of April 25, 2025, and employs firm fixed price terms with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves...
- The Defense Logistics Agency awarded a delivery order valued at $1,855.39 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication supplied in a 60-dose inhaler. The contract, awarded on October 31, 2025, with completion targeted for November 3, 2025, was competitively awarded with no set-aside designation. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3NVRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,402.28 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used in respiratory disease management. This firm fixed-price, competitively awarded contract was issued on November 12, 2025, with an ultimate completion date of November 13, 2025. AmerisourceBergen's Corporate Office, located in Conshohocken, Pennsylvania, serves as both the place of performance and the company's headquarters, leveraging its established infrastructure for federal pharmaceutical distribution. This delivery order represents a discrete transaction under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical prime vendor agreement running through December 2026. The parent IDC enables the contractor to supply a wide range of brand-name and generic pharmaceuticals, vaccines, and medical supplies to support military healthcare programs globally, including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen's designation as a pharmaceutical prime vendor reflects its critical role in sustaining the medical supply chain for military and veteran populations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.4k | 11/12/25 |